Page last updated: 2024-09-04

8-chloroadenosine-3',5'-cyclic monophosphorothioate and enkephalin, leucine

8-chloroadenosine-3',5'-cyclic monophosphorothioate has been researched along with enkephalin, leucine in 1 studies

Compound Research Comparison

Studies
(8-chloroadenosine-3',5'-cyclic monophosphorothioate)
Trials
(8-chloroadenosine-3',5'-cyclic monophosphorothioate)
Recent Studies (post-2010)
(8-chloroadenosine-3',5'-cyclic monophosphorothioate)
Studies
(enkephalin, leucine)
Trials
(enkephalin, leucine)
Recent Studies (post-2010) (enkephalin, leucine)
170111,52480754

Protein Interaction Comparison

ProteinTaxonomy8-chloroadenosine-3',5'-cyclic monophosphorothioate (IC50)enkephalin, leucine (IC50)
Delta-type opioid receptorMus musculus (house mouse)0.0142
Kappa-type opioid receptorMus musculus (house mouse)0.0417
Mu-type opioid receptorHomo sapiens (human)9.5
Mu-type opioid receptorMus musculus (house mouse)0.0308
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.246

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Christie, MJ; Hack, SP; Vaughan, CW1

Other Studies

1 other study(ies) available for 8-chloroadenosine-3',5'-cyclic monophosphorothioate and enkephalin, leucine

ArticleYear
Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro.
    Neuropharmacology, 2003, Volume: 45, Issue:5

    Topics: Action Potentials; Adenosine; Affinity Labels; Animals; Colforsin; Cyclic AMP; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Enkephalins; Enzyme Inhibitors; gamma-Aminobutyric Acid; In Vitro Techniques; Isoquinolines; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Neural Inhibition; Neurons; Patch-Clamp Techniques; Periaqueductal Gray; Probenecid; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome; Sulfonamides; Synaptic Transmission; Thioinosine; Time Factors; Uricosuric Agents; Vasodilator Agents; Xanthines

2003